UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 61

Sortiert nach

Neutrophilic dermatosis of the dorsal hands: Pustular vasculitis revisited

Journal of the American Academy of Dermatology, 2000-11, Vol.43 (5), p.870-874

2000

Volltextzugriff (PDF)

Eosinophilic fasciitis and eosinophilic cellulitis in a patient with abnormal circulating clonal T cells: increased production of interleukin 5 and inhibition by interferon alfa

Journal of the American Academy of Dermatology, 2003-12, Vol.49 (6), p.1170-1174

2003

Volltextzugriff (PDF)

Immunopathogenesis and therapy of cutaneous T cell lymphoma

The Journal of clinical investigation, 2005-04, Vol.115 (4), p.798-812

2005

Volltextzugriff (PDF)

Photopheresis: Clinical Applications and Mechanism of Action

The Journal of investigative dermatology symposium proceedings, 1999-09, Vol.4 (1), p.85-90

1999

Volltextzugriff (PDF)

Cutaneous smooth muscle neoplasms: Clinical features, histologic findings, and treatment options

Journal of the American Academy of Dermatology, 2002-04, Vol.46 (4), p.477-494

2002

Volltextzugriff (PDF)

Regression of multifocal, skin-restricted, CD30-positive large T-cell lymphoma with interferon alfa and bexarotene therapy

Journal of the American Academy of Dermatology, 2001-12, Vol.45 (6), p.914-918

2001

Volltextzugriff (PDF)

Desmoplastic fibroblastoma

Journal of cutaneous pathology, 1998-09, Vol.25 (8), p.450-454

1998

Volltextzugriff (PDF)

Nodular fasciitis

Archives of dermatology (1960), 2001-06, Vol.137 (6), p.719

2001

Volltextzugriff (PDF)

Percentage of gamma delta T Cells in Panniculitis by Paraffin Immunohistochemical Analysis

American journal of clinical pathology, 2009-06, Vol.131 (6)

2009

Volltextzugriff (PDF)

Low-dose oral bexarotene in combination with low-dose interferon alfa in the treatment of cutaneous T-cell lymphoma: clinical synergism and possible immunologic mechanisms

Journal of the American Academy of Dermatology, 2004-03, Vol.50 (3), p.375-379

2004

Volltextzugriff (PDF)

Necrolytic acral erythema: response to combination therapy with interferon and ribavirin

Journal of the American Academy of Dermatology, 2004-05, Vol.50 (5), p.121-124

2004

Volltextzugriff (PDF)

Therapeutic advances in biological response modifiers in the treatment of cutaneous T-cell lymphoma

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2001-01, Vol.15 (7), p.431-437

2001

Volltextzugriff (PDF)

Immunopathogenesis and therapy of cutaneous T cell lymphoma

The Journal of clinical investigation, 2007-03, Vol.117 (3), p.836-836

2007

Volltextzugriff (PDF)

Posttransplantation lymphoproliferative disease with features of lymphomatoid granulomatosis in a lung transplant patient

Journal of the American Academy of Dermatology, 2006-04, Vol.54 (4), p.657-663

2006

Volltextzugriff (PDF)

Progressive epidermotropic CD8+/CD4− primary cutaneous CD30+ lymphoproliferative disorder in a patient with sarcoidosis

Journal of the American Academy of Dermatology, 2004-08, Vol.51 (2), p.304-308

2004

Volltextzugriff (PDF)

Lupus erythematosus induced by medications, ultraviolet radiation, and other exogenous agents: A review, with special focus on the development of subacute cutaneous lupus erythematosus in a genetically predisposed individual

International journal of dermatology, 2004-02, Vol.43 (2), p.87-94

2004

Volltextzugriff (PDF)

Complete remission in advanced blastic NK‐cell lymphoma/leukemia in elderly patients using the hyper‐CVAD regimen

American journal of hematology, 2003-09, Vol.74 (1), p.46-51

2003

Volltextzugriff (PDF)

Assessment of tumor burden and treatment response by 18F-fluorodeoxyglucose injection and positron emission tomography in patients with cutaneous T- and B-cell lymphomas

Journal of the American Academy of Dermatology, 2002-10, Vol.47 (4), p.623-628

2002

Volltextzugriff (PDF)

Evaluation of the histologic characteristics of patch test confirmed allergic contact dermatitis

Journal of the American Academy of Dermatology, 2003-08, Vol.49 (2), p.243-248

2003

Volltextzugriff (PDF)

Manifestations of onchocerciasis

American family physician, 1995-10, Vol.52 (5), p.1286

1995

Volltextzugriff (PDF)

Novel multimodality biologic response modifier therapy, including bexarotene and long-wave ultraviolet A for a patient with refractory stage IVa cutaneous T-cell lymphoma

Journal of the American Academy of Dermatology, 2002-12, Vol.47 (6), p.956-961

2002

Volltextzugriff (PDF)

Treatment of stage IA cutaneous T-Cell lymphoma with topical application of the immune response modifier imiquimod

Archives of dermatology (1960), 2002-09, Vol.138 (9), p.1137

2002

Volltextzugriff (PDF)

Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors

Archives of dermatology (1960), 2006-02, Vol.142 (2), p.198

2006

Volltextzugriff (PDF)

Extracorporeal photopheresis and multimodality immunomodulatory therapy in the treatment of cutaneous T-cell lymphoma

Journal of cutaneous medicine and surgery, 2003-07, Vol.7 (4 Suppl), p.8-12

2003

Volltextzugriff (PDF)

Multiple painful oral ulcerations. Secondary syphilis

Archives of dermatology (1960), 1995-07, Vol.131 (7), p.833, 836

Junkins-Hopkins, J M

1995

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(43)

Publikationsform

Sprache

Englisch
(61)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Humans
(50)
Life Sciences & Biomedicine
(46)
Science & Technology
(46)
Dermatology
(41)
Biological And Medical Sciences
(33)
Medical Sciences
(33)
Female
(25)
Male
(23)
Middle Aged
(19)
Adult
(16)
Aged
(13)
Skin Neoplasms - Pathology
(13)
Follow-Up Studies
(10)
Hematologic And Hematopoietic Diseases
(10)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(10)
Skin Neoplasms - Drug Therapy
(10)
Biopsy, Needle
(9)
Diagnosis, Differential
(9)
Immunohistochemistry
(9)
Skin - Pathology
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Neutrophilic dermatosis of the dorsal hands: Pustular vasculitis revisited

Eosinophilic fasciitis and eosinophilic cellulitis in a patient with abnormal circulating clonal T cells: increased production of interleukin 5 and inhibition by interferon alfa

Immunopathogenesis and therapy of cutaneous T cell lymphoma

Photopheresis: Clinical Applications and Mechanism of Action

Cutaneous smooth muscle neoplasms: Clinical features, histologic findings, and treatment options

Regression of multifocal, skin-restricted, CD30-positive large T-cell lymphoma with interferon alfa and bexarotene therapy

Desmoplastic fibroblastoma

Nodular fasciitis

Percentage of gamma delta T Cells in Panniculitis by Paraffin Immunohistochemical Analysis

Low-dose oral bexarotene in combination with low-dose interferon alfa in the treatment of cutaneous T-cell lymphoma: clinical synergism and possible immunologic mechanisms

Necrolytic acral erythema: response to combination therapy with interferon and ribavirin

Therapeutic advances in biological response modifiers in the treatment of cutaneous T-cell lymphoma

Immunopathogenesis and therapy of cutaneous T cell lymphoma

Posttransplantation lymphoproliferative disease with features of lymphomatoid granulomatosis in a lung transplant patient

Progressive epidermotropic CD8+/CD4− primary cutaneous CD30+ lymphoproliferative disorder in a patient with sarcoidosis

Lupus erythematosus induced by medications, ultraviolet radiation, and other exogenous agents: A review, with special focus on the development of subacute cutaneous lupus erythematosus in a genetically predisposed individual

Complete remission in advanced blastic NK‐cell lymphoma/leukemia in elderly patients using the hyper‐CVAD regimen

Assessment of tumor burden and treatment response by 18F-fluorodeoxyglucose injection and positron emission tomography in patients with cutaneous T- and B-cell lymphomas

Evaluation of the histologic characteristics of patch test confirmed allergic contact dermatitis

Manifestations of onchocerciasis

Novel multimodality biologic response modifier therapy, including bexarotene and long-wave ultraviolet A for a patient with refractory stage IVa cutaneous T-cell lymphoma

Treatment of stage IA cutaneous T-Cell lymphoma with topical application of the immune response modifier imiquimod

Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors

Extracorporeal photopheresis and multimodality immunomodulatory therapy in the treatment of cutaneous T-cell lymphoma

Multiple painful oral ulcerations. Secondary syphilis

Suchergebnisse filtern